About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: To find a complete list of Publications, please see listing here.

 

Found 151 results
2023
A. Geerlinks, Scull, B., Krupski, C., Fleischmann, R., Pulsipher, M. A., Eapen, M., Connelly, J. A., Bollard, C. M., Pai, S. Y., Duncan, C., Kean, L. S., Baker, K. S., Burroughs, L., ,, Shenoy, S., Roehrs, P., Hanna, R., Talano, J. A., Schultz, K. R., Stenger, E. O., Lin, H., Zoref-Lorenz, A., McClain, K. L., Jordan, M. B., Man, T. K., Allen, C. E., and Marsh, R. A., “Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced intensity conditioning HCT. Blood Advances”, Blood Advances, 2023.
S. D. Ramsey, Bansal, A., Li, L., O'Donnell, P. V., Fuchs, E. J., Brunstein, C. G., Eapen, M., Thao, V., Roth, J. A., and Steuten, L. M. G., “Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101.”, Transplant Cell Ther, 2023.
N. El Jurdi, Martens, M. J., Brunstein, C. G., O'Donnell, P., Lee, S. J., D'Souza, A., Logan, B., Hong, S., Singh, A. K., Sandhu, K., Shapiro, R. M., Horowitz, M. M., and Hamilton, B. K., “Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101.”, Transplant Cell Ther, 2023.
M. Juckett, Dandoy, C., DeFilipp, Z., Kindwall-Keller, T. L., Spellman, S. R., Ustun, C., Waldman, B. M., Weisdorf, D. J., Wood, W. A., Horowitz, M. M., Burns, L. J., and Khera, N., “How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?”, Blood Rev, p. 101079, 2023.
M. Mohan, Janz, S., Brazauskas, R., Dwinell, M. B., Teng, B. Qing, Yun, G., Dong, J., Pasquini, M. C., Giralt, S., Landau, H., Stadtmauer, E., Krishnan, A., and D'Souza, A., “Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.”, Bone Marrow Transplant, 2023.
J. A. Hill, Martens, M. J., Young, J. - A. H., Bhavsar, K., Kou, J., Chen, M., Lee, L. Wee, Baluch, A., Dhodapkar, M. V., Nakamura, R., Peyton, K., Shahid, Z., Armistead, P., Westervelt, P., McCarty, J., McGuirk, J., Hamadani, M., DeWolf, S., Hosszu, K., Sharon, E., Spahn, A., Toor, A. A., Waldvogel, S., Greenberger, L. M., Auletta, J. J., Horowitz, M. M., Riches, M. L., and Perales, M. - A., “SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.”, EClinicalMedicine, vol. 59, p. 101983, 2023.
2022
B. K. Hamilton, Cutler, C., Divine, C., Juckett, M., LeMaistre, C., Stewart, S., Wilder, J., Horowitz, M., Khera, N., and Burns, L. J., “Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.”, Transplant Cell Ther, vol. 28, no. 8, pp. 419-425, 2022.
S. Vasu, Holtan, S. G., Shimamura, A., Burnworth, T., Whisenton, S., Adams, S., Nuechterlein, B., Mortier, N., Foster, J., DiFronzo, N., Horowitz, M., Rizzo, D., and Foley, A., “Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force.”, Transplant Cell Ther, vol. 29, no. 1, pp. 5-9, 2022.
T. - P. Lai, Verhulst, S., Dagnall, C. L., Hutchinson, A., Spellman, S. R., Howard, A., Katki, H. A., Levine, J. E., Saber, W., Aviv, A., and Gadalla, S. M., “Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202.”, Front Immunol, vol. 13, p. 966301, 2022.
L. Krishnamurti, Neuberg, D., Sullivan, K. M., Smith, S., Eapen, M., and Walters, M. C., “Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials.”, Transplant Cell Ther, vol. 29, no. 4, pp. 217-221, 2022.
A. E. DeZern, Eapen, M., Wu, J., Talano, J. - A., Solh, M., Saldaña, B. J. Dávila, Karanes, C., Horwitz, M. E., Mallhi, K., Arai, S., Farhadfar, N., Hexner, E., Westervelt, P., Antin, J. H., H Deeg, J., Leifer, E., Brodsky, R. A., Logan, B. R., Horowitz, M. M., Jones, R. J., and Pulsipher, M. A., “Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.”, Lancet Haematol, 2022.
R. Cusatis, Martens, M. J., Nakamura, R., Cutler, C. S., Saber, W., Lee, S. J., Logan, B. R., Shaw, B. E., Gregory, A., D'Souza, A., Hamilton, B. K., Horowitz, M. M., and Flynn, K. E., “Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102.”, Am J Hematol, vol. 98, no. 2, pp. 229-250, 2022.
C. G. Brunstein, O'Donnell, P. V., Logan, B., Dawson, P., Costa, L., Cutler, C., Craig, M., Hogan, W., Horowitz, M. M., Horwitz, M. E., Karanes, C., Magenau, J. M., Malone, A., McCarty, J., McGuirk, J. P., Morris, L. E., Rezvani, A. R., Salit, R., Vasu, S., Eapen, M., and Fuchs, E. J., “Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.”, Transplant Cell Ther, vol. 28, no. 7, pp. 406.e1-406.e6, 2022.
N. Farhadfar, Ahn, K. Woo, Bo-Subait, S., Logan, B., Stefanski, H. E., Hsu, J. W., Panch, S., Confer, D., Liu, H., Badawy, S. M., Beitinjaneh, A., Diaz, M. A., Hildebrandt, G. C., Kelkar, A. H., Lazarus, H. M., Murthy, H. S., Preussler, J. M., Schears, R. M., Sharma, A., van der Poel, M., Bruce, J. G., Pulsipher, M. A., Shaw, B. E., Wingard, J. R., and Switzer, G. E., “The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.”, Transplant Cell Ther, 2022.
A. Dispenzieri, Krishnan, A., Arendt, B., Blackwell, B., Wallace, P. K., Dasari, S., Vogl, D. T., Efebera, Y., Fei, M., Geller, N., Giralt, S., Hahn, T., Howard, A., Kohlhagen, M., Landau, H., Hari, P., Pasquini, M. C., Qazilbash, M. H., McCarthy, P., Shah, N., Vesole, D. H., Stadtmauer, E., and Murray, D., “Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT).”, Blood Cancer J, vol. 12, no. 2, p. 27, 2022.
Q. Bashir, Nishihori, T., Pasquini, M. C., Martens, M. J., Wu, J., Alsina, M., Anasetti, C., Brunstein, C., Dawson, P., Efebera, Y., Gasparetto, C., Geller, N., Giralt, S., Hall, A. C., Koreth, J., McCarthy, P., Scott, E., Stadtmauer, E. A., Vesole, D. H., and Hari, P., “A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial.”, Transplant Cell Ther, 2022.
S. A. Holstein, Asimakopoulos, F., Azab, A. Kareem, Bianchi, G., Bhutani, M., Crews, L. A., Cupedo, T., Giles, H., Gooding, S., Hillengass, J., John, L., Kaiser, S., Lee, L., Maclachlan, K., Pasquini, M. C., Pichiorri, F., Shah, N., Shokeen, M., Shy, B. R., Smith, E. L., Verona, R., Usmani, S. Z., and McCarthy, P. L., “Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.”, Transplant Cell Ther, vol. 28, no. 8, pp. 446-454, 2022.
S. Putta, Young, B. A., Levine, J. E., Reshef, R., Nakamura, R., Strouse, C., Perales, M. - A., Howard, A., Pine, P., Shi, J., Zhang, P., Ho, V. T., and Saber, W., “Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.”, Transplant Cell Ther, vol. 29, no. 3, pp. 166.e1-166.e10, 2022.
G. Thanarajasingam, Minasian, L. M., Bhatnagar, V., Cavalli, F., R De Claro, A., Dueck, A. C., El-Galaly, T. C., Everest, N., Geissler, J., Gisselbrecht, C., Gormley, N., Gribben, J., Horowitz, M., S Ivy, P., Jacobson, C. A., Keating, A., Kluetz, P. G., Kwong, Y. Lam, Little, R. F., Matasar, M. J., Mateos, M. - V., McCullough, K., Miller, R. S., Mohty, M., Moreau, P., Morton, L. M., Nagai, S., Nair, A., Nastoupil, L., Robertson, K., Sidana, S., Smedby, K. E., Sonneveld, P., Tzogani, K., van Leeuwen, F. E., Velikova, G., Villa, D., Wingard, J. R., Seymour, J. F., and Habermann, T. M., “Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.”, Lancet Haematol, vol. 9, no. 5, pp. e374-e384, 2022.
A. D'Souza, Brazauskas, R., Stadtmauer, E. A., Pasquini, M. C., Hari, P., Bashey, A., Callander, N., Devine, S., Efebera, Y., Ganguly, S., Gasparetto, C., Geller, N., Horowitz, M. M., Koreth, J., Landau, H., Brunstein, C., McCarthy, P., Qazilbash, M. H., Giralt, S., Krishnan, A., and Flynn, K. E., “Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.”, Am J Hematol, 2022.
P. G. Richardson, Jacobus, S. J., Weller, E. A., Hassoun, H., Lonial, S., Raje, N. S., Medvedova, E., McCarthy, P. L., Libby, E. N., Voorhees, P. M., Orlowski, R. Z., Anderson, L. D., Zonder, J. A., Milner, C. P., Gasparetto, C., Agha, M. E., Khan, A. M., Hurd, D. D., Gowin, K., Kamble, R. T., Jagannath, S., Nathwani, N., Alsina, M., R Cornell, F., Hashmi, H., Campagnaro, E. L., Andreescu, A. C., Gentile, T., Liedtke, M., Godby, K. N., Cohen, A. D., Openshaw, T. H., Pasquini, M. C., Giralt, S. A., Kaufman, J. L., Yee, A. J., Scott, E., Torka, P., Foley, A., Fulciniti, M., Hebert, K., Samur, M. K., Masone, K., Maglio, M. E., Zeytoonjian, A. A., Nadeem, O., Schlossman, R. L., Laubach, J. P., Paba-Prada, C., Ghobrial, I. M., Perrot, A., Moreau, P., Avet-Loiseau, H., Attal, M., Anderson, K. C., and Munshi, N. C., “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.”, N Engl J Med, vol. 387, no. 2, pp. 132-147, 2022.
S. Castro-Pearson, Le, C. T., and Luo, X., “Two-sample survival probability curves: A graphical approach for the analysis of time to event data in clinical trials.”, Contemp Clin Trials, vol. 115, p. 106707, 2022.
2021
S. A. Holstein, Bahlis, N., P Bergsagel, L., Bhutani, M., Bolli, N., Brownstein, C., Demolis, P., Foureau, D., Gay, F., Ghobrial, I. M., Gormley, N., Hillengass, J., Kaiser, M., Maus, M. V., J Melenhorst, J., Merz, M., Dwyer, M. O., Paiva, B., Pasquini, M. C., Shah, N., Wong, S. W., Usmani, S. Z., and McCarthy, P. L., “The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.”, Transplant Cell Ther, vol. 27, no. 10, pp. 807-816, 2021.
R. Reshef, Saber, W., Bolaños-Meade, J., Chen, G., Bin Chen, Y. -, Ho, V. T., Ponce, D. M., Nakamura, R., Martens, M. J., Hansen, J. A., and Levine, J. E., “Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study.”, J Clin Oncol, vol. 39, no. 17, pp. 1878-1887, 2021.
R. Nakamura, Saber, W., Martens, M. J., Ramirez, A., Scott, B., Oran, B., Leifer, E., Tamari, R., Mishra, A., Maziarz, R. T., McGuirk, J., Westervelt, P., Vasu, S., Patnaik, M., Kamble, R., Forman, S. J., Sekeres, M. A., Appelbaum, F., Mendizabal, A., Logan, B., Horowitz, M., and Cutler, C., “Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome.”, J Clin Oncol, vol. 39, no. 30, pp. 3328-3339, 2021.